Division of Pediatric Hematology/Oncology
A team of Board-certified pediatric hematologists/oncologists provide comprehensive care for pediatric, adolescent, and young adult patients with blood disorders and cancer. Physicians in the Hematology/Oncology Division have expertise in sickle cell disease, hemophilia, bleeding disorders, strokes and other clotting problems, bone marrow failure syndromes, and abnormalities of red blood cells, white blood cells, and platelets.
The Division is an active member of the University of Maryland’s Greenebaum Cancer Center, which is designated by the National Cancer Institute, and Children’s Oncology Group. Participation allows pediatric patients with cancer to receive access to state-of-the art clinical trials being conducted nationally. In addition, the Division offers a new Cancer Survivor Program for survivors of pediatric cancers of any age to receive long-term follow up care.
- University of Maryland Medical Center, Downtown Baltimore
- Upper Chesapeake Health Center, Bel Air, MD
AREAS of EXPERTISE
- Sickle cell disease
- Bleeding disorders and abnormal blood clotting
- Bone marrow failure syndromes
- Pediatric solid tumors
- Cancer survivorship
Cancer Survivor Program
The Cancer Survivor Program at the University of Maryland offers evidence-based, individualized follow of pediatric cancer survivors to help them anticipate late effects of therapy and promote health. Survivors become eligible when they are off therapy for two years and are cancer-free. The Cancer Survivor Program is available to cancer survivors from the Baltimore area, state, and larger community.
Teresa York, MD
Assistant Professor of Pediatrics
Special Interests: pediatric leukemia and lymphoma
Principal Investigator, Children’s Oncology Group
Board certified in Pediatrics and Hematology Oncology
- Diane Keegan Wells, RN, M S. CPNP, Pediatric Hematology/Oncology nurse practitioner
- Chrissy Rhoads, RN
- Tracy Nishida, RN
- Erin Garner, MSW